申请人:TAKEDA PHARMACEUTICAL COMPANY LIMITED
公开号:US09133129B2
公开(公告)日:2015-09-15
The present invention provides a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof.
本发明提供了一种由式(I)表示的化合物,其中每个符号如规范中所定义,或其盐。